anf-2022073000010188401/287/30/20222022Q2false139,75117,159159,423230,83600010188402022-01-302022-07-3000010188402022-09-02xbrli:shares00010188402022-05-012022-07-30iso4217:USD00010188402021-05-022021-07-3100010188402021-01-312021-07-31iso4217:USDxbrli:shares00010188402022-07-3000010188402022-01-290001018840us-gaap:CommonClassAMember2022-01-290001018840us-gaap:CommonClassAMember2022-07-300001018840us-gaap:TreasuryStockMember2022-07-300001018840us-gaap:TreasuryStockMember2022-01-290001018840us-gaap:CommonStockMember2022-04-300001018840us-gaap:AdditionalPaidInCapitalMember2022-04-300001018840us-gaap:NoncontrollingInterestMember2022-04-300001018840us-gaap:RetainedEarningsMember2022-04-300001018840us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-04-300001018840us-gaap:TreasuryStockMember2022-04-3000010188402022-04-300001018840us-gaap:NoncontrollingInterestMember2022-05-012022-07-300001018840us-gaap:RetainedEarningsMember2022-05-012022-07-300001018840us-gaap:CommonStockMember2022-05-012022-07-300001018840us-gaap:TreasuryStockMember2022-05-012022-07-300001018840us-gaap:AdditionalPaidInCapitalMember2022-05-012022-07-300001018840us-gaap:CommonStockMember2022-07-300001018840us-gaap:AdditionalPaidInCapitalMember2022-07-300001018840us-gaap:NoncontrollingInterestMember2022-07-300001018840us-gaap:RetainedEarningsMember2022-07-300001018840us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-07-300001018840us-gaap:CommonStockMember2021-05-010001018840us-gaap:AdditionalPaidInCapitalMember2021-05-010001018840us-gaap:NoncontrollingInterestMember2021-05-010001018840us-gaap:RetainedEarningsMember2021-05-010001018840us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-05-010001018840us-gaap:TreasuryStockMember2021-05-0100010188402021-05-010001018840us-gaap:NoncontrollingInterestMember2021-05-022021-07-310001018840us-gaap:RetainedEarningsMember2021-05-022021-07-310001018840us-gaap:CommonStockMember2021-05-022021-07-310001018840us-gaap:TreasuryStockMember2021-05-022021-07-310001018840us-gaap:AdditionalPaidInCapitalMember2021-05-022021-07-310001018840us-gaap:CommonStockMember2021-07-310001018840us-gaap:AdditionalPaidInCapitalMember2021-07-310001018840us-gaap:NoncontrollingInterestMember2021-07-310001018840us-gaap:RetainedEarningsMember2021-07-310001018840us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-07-310001018840us-gaap:TreasuryStockMember2021-07-3100010188402021-07-310001018840us-gaap:CommonStockMember2022-01-290001018840us-gaap:AdditionalPaidInCapitalMember2022-01-290001018840us-gaap:NoncontrollingInterestMember2022-01-290001018840us-gaap:RetainedEarningsMember2022-01-290001018840us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-01-290001018840us-gaap:NoncontrollingInterestMember2022-01-302022-07-300001018840us-gaap:RetainedEarningsMember2022-01-302022-07-300001018840us-gaap:CommonStockMember2022-01-302022-07-300001018840us-gaap:TreasuryStockMember2022-01-302022-07-300001018840us-gaap:AdditionalPaidInCapitalMember2022-01-302022-07-300001018840us-gaap:CommonStockMember2021-01-300001018840us-gaap:AdditionalPaidInCapitalMember2021-01-300001018840us-gaap:NoncontrollingInterestMember2021-01-300001018840us-gaap:RetainedEarningsMember2021-01-300001018840us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-01-300001018840us-gaap:TreasuryStockMember2021-01-3000010188402021-01-300001018840us-gaap:NoncontrollingInterestMember2021-01-312021-07-310001018840us-gaap:RetainedEarningsMember2021-01-312021-07-310001018840us-gaap:CommonStockMember2021-01-312021-07-310001018840us-gaap:TreasuryStockMember2021-01-312021-07-310001018840us-gaap:AdditionalPaidInCapitalMember2021-01-312021-07-310001018840us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-07-300001018840us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-07-300001018840us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-07-300001018840us-gaap:FairValueMeasurementsRecurringMember2022-07-300001018840us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-01-290001018840us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-01-290001018840us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-01-290001018840us-gaap:FairValueMeasurementsRecurringMember2022-01-290001018840anf:TermLoanFacilityMemberDomain2022-07-300001018840anf:TermLoanFacilityMemberDomain2022-01-290001018840us-gaap:SeniorNotesMember2022-07-300001018840us-gaap:FairValueMeasurementsRecurringMember2021-07-310001018840country:CN2022-07-300001018840anf:ABLFacilityMemberDomain2022-07-300001018840anf:ServicebasedrestrictedstockunitsMember2022-01-290001018840anf:PerformancebasedrestrictedstockunitsMember2022-01-290001018840anf:MarketbasedrestrictedstockunitsMember2022-01-290001018840anf:ServicebasedrestrictedstockunitsMember2022-01-302022-07-300001018840anf:PerformancebasedrestrictedstockunitsMember2022-01-302022-07-300001018840anf:MarketbasedrestrictedstockunitsMember2022-01-302022-07-300001018840anf:ServicebasedrestrictedstockunitsMember2022-07-300001018840anf:PerformancebasedrestrictedstockunitsMember2022-07-300001018840anf:MarketbasedrestrictedstockunitsMember2022-07-300001018840anf:ServicebasedrestrictedstockunitsMember2021-01-312021-07-310001018840anf:PerformancebasedrestrictedstockunitsMember2021-01-312021-07-310001018840anf:MarketbasedrestrictedstockunitsMember2021-01-312021-07-31xbrli:pure0001018840currency:EUR2022-07-300001018840currency:GBP2022-07-300001018840currency:CAD2022-07-300001018840currency:JPY2022-07-300001018840us-gaap:DesignatedAsHedgingInstrumentMember2022-07-300001018840us-gaap:DesignatedAsHedgingInstrumentMember2022-01-290001018840us-gaap:NondesignatedMember2022-07-300001018840us-gaap:NondesignatedMember2022-01-290001018840us-gaap:AccumulatedTranslationAdjustmentMember2022-04-300001018840us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-04-300001018840us-gaap:AccumulatedTranslationAdjustmentMember2022-05-012022-07-300001018840us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-05-012022-07-300001018840us-gaap:AccumulatedTranslationAdjustmentMember2022-07-300001018840us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-07-300001018840us-gaap:AccumulatedTranslationAdjustmentMember2022-01-290001018840us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-01-290001018840us-gaap:AccumulatedTranslationAdjustmentMember2022-01-302022-07-300001018840us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-01-302022-07-300001018840us-gaap:AccumulatedTranslationAdjustmentMember2021-05-010001018840us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-05-010001018840us-gaap:AccumulatedTranslationAdjustmentMember2021-05-022021-07-310001018840us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-05-022021-07-310001018840us-gaap:AccumulatedTranslationAdjustmentMember2021-07-310001018840us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-07-310001018840us-gaap:AccumulatedTranslationAdjustmentMember2021-01-300001018840us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-300001018840us-gaap:AccumulatedTranslationAdjustmentMember2021-01-312021-07-310001018840us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-312021-07-310001018840anf:HollisterMember2022-05-012022-07-300001018840anf:HollisterMember2021-05-022021-07-310001018840anf:HollisterMember2022-01-302022-07-300001018840anf:HollisterMember2021-01-312021-07-310001018840anf:AbercrombieMember2022-05-012022-07-300001018840anf:AbercrombieMember2021-05-022021-07-310001018840anf:AbercrombieMember2022-01-302022-07-300001018840anf:AbercrombieMember2021-01-312021-07-310001018840country:US2022-05-012022-07-300001018840country:US2021-05-022021-07-310001018840country:US2022-01-302022-07-300001018840country:US2021-01-312021-07-310001018840us-gaap:EMEAMember2022-05-012022-07-300001018840us-gaap:EMEAMember2021-05-022021-07-310001018840us-gaap:EMEAMember2022-01-302022-07-300001018840us-gaap:EMEAMember2021-01-312021-07-310001018840srt:AsiaPacificMember2022-05-012022-07-300001018840srt:AsiaPacificMember2021-05-022021-07-310001018840srt:AsiaPacificMember2022-01-302022-07-300001018840srt:AsiaPacificMember2021-01-312021-07-310001018840anf:OtherLocationsMember2022-05-012022-07-300001018840anf:OtherLocationsMember2021-05-022021-07-310001018840anf:OtherLocationsMember2022-01-302022-07-300001018840anf:OtherLocationsMember2021-01-312021-07-310001018840anf:InternationalMember2022-05-012022-07-300001018840anf:InternationalMember2021-05-022021-07-310001018840anf:InternationalMember2022-01-302022-07-300001018840anf:InternationalMember2021-01-312021-07-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
| | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended July 30, 2022
or | | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 001-12107
Abercrombie & Fitch Co.
(Exact name of Registrant as specified in its charter)
| | | | | | | | | | | | | | |
Delaware | | 31-1469076 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| | | | |
6301 Fitch Path, | New Albany, | Ohio | | 43054 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: | (614) | 283-6500 |
| | |
Not Applicable |
(Former name, former address and former fiscal year, if changed since last report) |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Class A Common Stock, $0.01 Par Value | | ANF | | New York Stock Exchange |
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes ¨ No
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). x Yes ¨ No
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. | | | | | | | | | | | |
Large accelerated filer | x | Accelerated filer | ¨ |
Non-accelerated filer | ¨ | Smaller reporting company | ☐ |
| | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes x No
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
| | | | | | | | |
Class A Common Stock | | Shares outstanding as of September 2, 2022 |
$0.01 Par Value | | 49,453,619 |
Table of Contents
| | | | | | | | |
|
Item 1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
Item 2. | | |
Item 3. | | |
Item 4. | | |
|
Item 1. | | |
Item 1A. | | |
Item 2. | | |
Item 6. | | |
| | |
| | | | | | | | |
Abercrombie & Fitch Co. | 2 | 2022 2Q Form 10-Q |
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Abercrombie & Fitch Co.
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income
(Thousands, except per share amounts)
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Thirteen Weeks Ended | | Twenty-Six Weeks Ended |
| July 30, 2022 | | July 31, 2021 | | July 30, 2022 | | July 31, 2021 |
Net sales | $ | 805,091 | | | $ | 864,850 | | | $ | 1,617,853 | | | $ | 1,646,255 | |
Cost of sales, exclusive of depreciation and amortization | 339,200 | | | 301,365 | | | 702,416 | | | 587,636 | |
Gross profit | 465,891 | | | 563,485 | | | 915,437 | | | 1,058,619 | |
Stores and distribution expense | 340,791 | | | 325,847 | | | 678,334 | | | 641,355 | |
Marketing, general and administrative expense | 124,168 | | | 123,913 | | | 246,317 | | | 244,860 | |
Flagship store exit benefits | — | | | — | | | — | | | — | |
Asset impairment | 2,170 | | | 786 | | | 5,592 | | | 3,450 | |
Other operating expense (income), net | 953 | | | (1,848) | | | (2,889) | | | (3,266) | |
Operating (loss) income | (2,191) | | | 114,787 | | | (11,917) | | | 172,220 | |
Interest expense, net | 6,917 | | | 11,275 | | | 14,224 | | | 19,881 | |
(Loss) income before income taxes | (9,108) | | | 103,512 | | | (26,141) | | | 152,339 | |
Income tax expense (benefit) | 5,634 | | | (6,944) | | | 3,447 | | | (823) | |
Net (loss) income | (14,742) | | | 110,456 | | | (29,588) | | | 153,162 | |
Less: Net income attributable to noncontrolling interests | 2,092 | | | 1,956 | | | 3,715 | | | 2,894 | |
Net (loss) income attributable to A&F | $ | (16,834) | | | $ | 108,500 | | | $ | (33,303) | | | $ | 150,268 | |
| | | | | | | |
Net (loss) income attributable to A&F per share | | | | | | | |
Basic | $ | (0.33) | | | $ | 1.77 | | | $ | (0.65) | | | $ | 2.43 | |
Diluted | $ | (0.33) | | | $ | 1.69 | | | $ | (0.65) | | | $ | 2.32 | |
| | | | | | | |
Weighted-average shares outstanding | | | | | | | |
Basic | 50,441 | | | 61,428 | | | 51,262 | | | 61,914 | |
Diluted | 50,441 | | | 64,136 | | | 51,262 | | | 64,803 | |
| | | | | | | |
Other comprehensive (loss) income | | | | | | | |
Foreign currency translation adjustments, net of tax | $ | (4,914) | | | $ | (1,986) | | | $ | (15,317) | | | $ | (3,260) | |
Derivative financial instruments, net of tax | (1,729) | | | 2,703 | | | (17) | | | 5,302 | |
Other comprehensive (loss) income | (6,643) | | | 717 | | | (15,334) | | | 2,042 | |
Comprehensive (loss) income | (21,385) | | | 111,173 | | | (44,922) | | | 155,204 | |
Less: Comprehensive income attributable to noncontrolling interests | 2,092 | | | 1,956 | | | 3,715 | | | 2,894 | |
Comprehensive (loss) income attributable to A&F | $ | (23,477) | | | $ | 109,217 | | | $ | (48,637) | | | $ | 152,310 | |
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.
| | | | | | | | |
Abercrombie & Fitch Co. | 3 | 2022 2Q Form 10-Q |
Abercrombie & Fitch Co.
Condensed Consolidated Balance Sheets
(Thousands, except par value amounts)
(Unaudited)
| | | | | | | | | | | |
| July 30, 2022 | | January 29, 2022 |
Assets | | | |
Current assets: | | | |
Cash and equivalents | $ | 369,957 | | | $ | 823,139 | |
Receivables | 79,820 | | | 69,102 | |
Inventories | 708,024 | | | 525,864 | |
Other current assets | 104,887 | | | 89,654 | |
Total current assets | 1,262,688 | | | 1,507,759 | |
Property and equipment, net | 511,181 | | | 508,336 | |
Operating lease right-of-use assets | 740,627 | | | 698,231 | |
Other assets | 219,598 | | | 225,165 | |
Total assets | $ | 2,734,094 | | | $ | 2,939,491 | |
Liabilities and stockholders’ equity | | | |
Current liabilities: | | | |
Accounts payable | $ | 408,297 | | | $ | 374,829 | |
Accrued expenses | 342,690 | | | 395,815 | |
Short-term portion of operating lease liabilities | 202,699 | | | 222,823 | |
Income taxes payable | 5,582 | | | 21,773 | |
Total current liabilities | 959,268 | | | 1,015,240 | |
Long-term liabilities: | | | |
Long-term portion of operating lease liabilities | 714,265 | | | 697,264 | |
Long-term borrowings, net | 304,219 | | | 303,574 | |
Other liabilities | 83,415 | | | 86,089 | |
Total long-term liabilities | 1,101,899 | | | 1,086,927 | |
Stockholders’ equity | | | |
Class A Common Stock: $0.01 par value: 150,000 shares authorized and 103,300 shares issued for all periods presented | 1,033 | | | 1,033 | |
Paid-in capital | 405,127 | | | 413,190 | |
Retained earnings | 2,333,867 | | | 2,386,156 | |
Accumulated other comprehensive loss, net of tax (“AOCL”) | (130,040) | | | (114,706) | |
Treasury stock, at average cost: 53,829 and 50,315 shares as of July 30, 2022 and January 29, 2022, respectively | (1,948,199) | | | (1,859,583) | |
Total Abercrombie & Fitch Co. stockholders’ equity | 661,788 | | | 826,090 | |
Noncontrolling interests | 11,139 | | | 11,234 | |
Total stockholders’ equity | 672,927 | | | 837,324 | |
Total liabilities and stockholders’ equity | $ | 2,734,094 | | | $ | 2,939,491 | |
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.
| | | | | | | | |
Abercrombie & Fitch Co. | 4 | 2022 2Q Form 10-Q |
Abercrombie & Fitch Co.
Condensed Consolidated Statements of Stockholders’ Equity
(Thousands, except per share amounts)
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Thirteen Weeks Ended July 30, 2022 |
| Common Stock | Paid-in capital | Non-controlling interests | Retained earnings | AOCL | Treasury stock | Total stockholders’ equity |
| Shares outstanding | Par value | Shares | At average cost |
Balance, April 30, 2022 | 50,442 | | $ | 1,033 | | $ | 398,412 | | $ | 9,444 | | $ | 2,350,807 | | $ | (123,397) | | 52,858 | | $ | (1,931,494) | | $ | 704,805 | |
Net loss | — | | — | | — | | 2,092 | | (16,834) | | — | | — | | — | | (14,742) | |
Purchase of Common Stock | (1,000) | | — | | — | | — | | — | | — | | 1,000 | | (17,775) | | (17,775) | |
| | | | | | | | | |
Share-based compensation issuances and exercises | 29 | | — | | (1,045) | | — | | (106) | | — | | (29) | | 1,070 | | (81) | |
Share-based compensation expense | — | | — | | 7,760 | | — | | — | | — | | — | | — | | 7,760 | |
Derivative financial instruments, net of tax | — | | — | | — | | — | | — | | (1,729) | | — | | — | | (1,729) | |
Foreign currency translation adjustments, net of tax | — | | — | | — | | — | | — | | (4,914) | | — | | — | | (4,914) | |
Distributions to noncontrolling interests, net | — | | — | | — | | (397) | | — | | — | | — | | — | | (397) | |
Ending balance at July 30, 2022 | 49,471 | | $ | 1,033 | | $ | 405,127 | | $ | 11,139 | | $ | 2,333,867 | | $ | (130,040) | | 53,829 | | $ | (1,948,199) | | $ | 672,927 | |
| | | | | | | | | |
| Thirteen Weeks Ended July 31, 2021 |
| Common Stock | Paid-in capital | Non-controlling interests | Retained earnings | AOCL | Treasury stock | Total stockholders’ equity |
| Shares outstanding | Par value | Shares | At average cost |
Balance, May 1, 2021 | 61,935 | | $ | 1,033 | | $ | 395,277 | | $ | 8,776 | | $ | 2,169,748 | | $ | (100,982) | | 41,365 | | $ | (1,523,902) | | $ | 949,950 | |
Net income | — | | — | | — | | 1,956 | | 108,500 | | — | | — | | — | | 110,456 | |
Purchase of Common Stock | (2,374) | | — | | — | | — | | | | 2,374 | | (100,000) | | (100,000) | |
| | | | | | | | | |
Share-based compensation issuances and exercises | 130 | | — | | (1,873) | | — | | (3,239) | | — | | (130) | | 4,800 | | (312) | |
Share-based compensation expense | — | | — | | 6,487 | | — | | — | | — | | — | | — | | 6,487 | |
Derivative financial instruments, net of tax | — | | — | | — | | — | | — | | 2,703 | | — | | — | | 2,703 | |
Foreign currency translation adjustments, net of tax | — | | — | | — | | — | | — | | (1,986) | | — | | — | | (1,986) | |
Distributions to noncontrolling interests, net | — | | — | | — | | (365) | | — | | — | | — | | — | | (365) | |
Ending balance at July 31, 2021 | 59,691 | | $ | 1,033 | | $ | 399,891 | | $ | 10,367 | | $ | 2,275,009 | | $ | (100,265) | | 43,609 | | $ | (1,619,102) | | $ | 966,933 | |
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.
| | | | | | | | |
Abercrombie & Fitch Co. | 5 | 2022 2Q Form 10-Q |
Abercrombie & Fitch Co.
Condensed Consolidated Statements of Stockholders’ Equity
(Thousands, except per share amounts)
(Unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Twenty-Six Weeks Ended July 30, 2022 |
| Common Stock | Paid-in capital | Non-controlling interests | Retained earnings | AOCL | Treasury stock | Total stockholders’ equity |
| Shares outstanding | Par value | Shares | At average cost |
Balance, January 29, 2022 | 52,985 | | $ | 1,033 | | $ | 413,190 | | $ | 11,234 | | $ | 2,386,156 | | $ | (114,706) | | 50,315 | | $ | (1,859,583) | | $ | 837,324 | |
Net loss | — | | — | | — | | 3,715 | | (33,303) | | — | | — | | — | | (29,588) | |
Purchase of Common Stock | (4,260) | | — | | — | | — | | — | | — | | 4,260 | | (117,775) | | (117,775) | |
| | | | | | | | | |
Share-based compensation issuances and exercises | 746 | | — | | (24,179) | | — | | (18,986) | | — | | (746) | | 29,159 | | (14,006) | |
Share-based compensation expense | — | | — | | 16,116 | | — | | — | | — | | — | | — | | 16,116 | |
Derivative financial instruments, net of tax | — | | — | | — | | — | | — | | (17) | | — | | — | | (17) | |
Foreign currency translation adjustments, net of tax | — | | — | | — | | — | | — | | (15,317) | | — | | — | | (15,317) | |
Distributions to noncontrolling interests, net | — | | — | | — | | (3,810) | | — | | — | | — | | — | | (3,810) | |
Ending balance at July 30, 2022 | 49,471 | | $ | 1,033 | | $ | 405,127 | | $ | 11,139 | | $ | 2,333,867 | | $ | (130,040) | | 53,829 | | $ | (1,948,199) | | $ | 672,927 | |
| | | | | | | | | |
| Twenty-Six Weeks Ended July 31, 2021 |
| Common Stock | Paid-in capital | Non-controlling interests | Retained earnings | AOCL | Treasury stock | Total stockholders’ equity |
| Shares outstanding | Par value | Shares | At average cost |
Balance, January 30, 2021 | 62,399 | | $ | 1,033 | | $ | 401,283 | | $ | 12,684 | | $ | 2,149,470 | | $ | (102,307) | | 40,901 | | $ | (1,512,851) | | $ | 949,312 | |
Net income | — | | — | | — | | 2,894 | | 150,268 | | — | | — | | — | | 153,162 | |
Purchase of Common Stock | (3,451) | | — | | — | | — | | | | 3,451 | | (135,249) | | (135,249) | |
| | | | | | | | | |
Share-based compensation issuances and exercises | 743 | | — | | (16,329) | | — | | (24,729) | | — | | (743) | | 28,998 | | (12,060) | |
Share-based compensation expense | — | | — | | 14,937 | | — | | — | | — | | — | | — | | 14,937 | |
Derivative financial instruments, net of tax | — | | — | | — | | — | | — | | 5,302 | | — | | — | | 5,302 | |
Foreign currency translation adjustments, net of tax | — | | — | | — | | — | | — | | (3,260) | | — | | — | | (3,260) | |
Distributions to noncontrolling interests, net | — | | — | | — | | (5,211) | | — | | — | | — | | — | | (5,211) | |
Ending balance at July 31, 2021 | 59,691 | | $ | 1,033 | | $ | 399,891 | | $ | 10,367 | | $ | 2,275,009 | | $ | (100,265) | | 43,609 | | $ | (1,619,102) | | $ | 966,933 | |
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.
| | | | | | | | |
Abercrombie & Fitch Co. | 6 | 2022 2Q Form 10-Q |
Abercrombie & Fitch Co.
Condensed Consolidated Statements of Cash Flows
(Thousands)
(Unaudited)
| | | | | | | | | | | |
| Twenty-Six Weeks Ended |
| | | |
| July 30, 2022 | | July 31, 2021 |
Operating activities | | | |
Net (loss) income | $ | (29,588) | | | $ | 153,162 | |
Adjustments to reconcile net (loss) income to net cash (used for) provided by operating activities: | | | |
Depreciation and amortization | 65,543 | | | 72,249 | |
Asset impairment | 5,592 | | | 3,450 | |
(Gain) loss on disposal | (1,083) | | | 2,188 | |
Benefit for deferred income taxes | (1,629) | | | (21,187) | |
Share-based compensation | 16,116 | | | 14,937 | |
Loss on extinguishment of debt | — | | | 5,347 | |
Changes in assets and liabilities: | | | |
Inventories | (184,657) | | | (11,849) | |
Accounts payable and accrued expenses | (34,013) | | | (63,562) | |
Operating lease right-of-use assets and liabilities | (41,122) | | | (93,040) | |
Income taxes | (17,154) | | | 1,379 | |
Other assets | (38,436) | | | (11,575) | |
Other liabilities | 698 | | | (1,554) | |
Net cash (used for) provided by operating activities | (259,733) | | | 49,945 | |
Investing activities | | | |
Purchases of property and equipment | (59,582) | | | (35,269) | |
Proceeds from the sale of property and equipment | 7,972 | | | — | |
Net cash used for investing activities | (51,610) | | | (35,269) | |
Financing activities | | | |
| | | |
Purchase of senior secured notes | — | | | (46,969) | |
| | | |
| | | |
| | | |
Payment of debt issuance or modification costs and fees | — | | | (1,837) | |
Purchases of Common Stock | (117,775) | | | (135,249) | |
| | | |
Other financing activities | (17,649) | | | (16,192) | |
Net cash used for financing activities | (135,424) | | | (200,247) | |
Effect of foreign currency exchange rates on cash | (7,567) | | | (2,547) | |
Net decrease in cash and equivalents, and restricted cash and equivalents | (454,334) | | | (188,118) | |
Cash and equivalents, and restricted cash and equivalents, beginning of period | 834,368 | | | 1,124,157 | |
Cash and equivalents, and restricted cash and equivalents, end of period | $ | 380,034 | | | $ | 936,039 | |
Supplemental information related to non-cash activities | | | |
Purchases of property and equipment not yet paid at end of period | $ | 50,133 | | | $ | 35,789 | |
Operating lease right-of-use assets additions, net of terminations, impairments and other reductions | 139,751 | | | 17,159 | |
Supplemental information related to cash activities | | | |
Cash paid for interest | 13,463 | | | 14,950 | |
Cash paid for income taxes | 24,566 | | | 24,132 | |
Cash received from income tax refunds | 139 | | | 570 | |
Cash paid for amounts included in measurement of operating lease liabilities, net of abatements | 159,423 | | | 230,836 | |
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.
| | | | | | | | |
Abercrombie & Fitch Co. | 7 | 2022 2Q Form 10-Q |
Abercrombie & Fitch Co.
Index for Notes to Condensed Consolidated Financial Statements (Unaudited)
| | | | | | | | |
| | Page No. |
Note 1. | | |
Note 2. | | |
| | |
Note 3. | | |
Note 4. | | |
Note 5. | | |
Note 6. | | |
Note 7. | | |
Note 8. | | |
Note 9. | | |
Note 10. | | |
Note 11. | | |
Note 12. | | |
Note 13. | | |
Note 14. | | |
| | |
| | |
| | | | | | | | |
Abercrombie & Fitch Co. | 8 | 2022 2Q Form 10-Q |
Abercrombie & Fitch Co.
Notes to Condensed Consolidated Financial Statements (Unaudited)
1. NATURE OF BUSINESS
Abercrombie & Fitch Co. (“A&F”), a company incorporated in Delaware in 1996, through its subsidiaries (collectively, A&F and its subsidiaries are referred to as “Abercrombie & Fitch” or the “Company”), is a global, digitally-led omnichannel retailer. The Company offers a broad assortment of apparel, personal care products and accessories for men, women and kids, which are sold primarily through its digital channels and Company-owned stores, as well as through various third-party arrangements. The Company’s two brand-based operating segments are Hollister, which includes the Company’s Hollister, Gilly Hicks and Social Tourist brands, and Abercrombie, which includes the Company’s Abercrombie & Fitch and abercrombie kids brands. These five brands share a commitment to offering unique products of enduring quality and exceptional comfort that allow customers around the world to express their own individuality and style. The Company operates primarily in North America, Europe and Asia.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of consolidation
The accompanying Condensed Consolidated Financial Statements include historical financial statements of, and transactions applicable to, the Company and reflect its financial position, results of operations and cash flows.
The Company has interests in an Emirati business venture and in a Kuwaiti business venture with Majid al Futtaim Fashion L.L.C. (“MAF”) and in a United States of America (the “U.S.”) business venture with Dixar L.L.C. (“Dixar”), each of which meets the definition of a variable interest entity (“VIE”). The purpose of the business ventures with MAF is to operate stores in the United Arab Emirates and Kuwait and the purpose of the business venture with Dixar is to hold the intellectual property related to the Social Tourist brand. The Company is deemed to be the primary beneficiary of these VIEs; therefore, the Company has consolidated the operating results, assets and liabilities of these VIEs, with the noncontrolling interests’ (“NCI”) portions of net income presented as net income attributable to NCI on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income and the NCI portion of stockholders’ equity presented as NCI on the Condensed Consolidated Balance Sheets.
Fiscal year
The Company’s fiscal year ends on the Saturday closest to January 31. This typically results in a fifty-two week year, but occasionally gives rise to an additional week, resulting in a fifty-three week year. Fiscal years are designated in the Condensed Consolidated Financial Statements and notes, as well as the remainder of this Quarterly Report on Form 10-Q, by the calendar year in which the fiscal year commences. All references herein to the Company’s fiscal years are as follows:
| | | | | | | | | | | | | | |
Fiscal year | | Year ended/ ending | | Number of weeks |
Fiscal 2021 | | January 29, 2022 | | 52 |
Fiscal 2022 | | January 28, 2023 | | 52 |
Fiscal 2023 | | February 3, 2024 | | 53 |
Interim financial statements
The Condensed Consolidated Financial Statements as of July 30, 2022, and for the thirteen and twenty-six week periods ended July 30, 2022 and July 31, 2021, are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim consolidated financial statements. Accordingly, the Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and notes thereto contained in A&F’s Annual Report on Form 10-K for Fiscal 2021 filed with the SEC on March 28, 2022 (the “Fiscal 2021 Form 10-K”). The January 29, 2022 consolidated balance sheet data, included herein, were derived from audited consolidated financial statements, but do not include all disclosures required by accounting principles generally accepted in the U.S. (“GAAP”).
In the opinion of management, the accompanying Condensed Consolidated Financial Statements reflect all adjustments (which are of a normal recurring nature) necessary to state fairly, in all material respects, the financial position, results of operations and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for Fiscal 2022.
During the first quarter of 2022, the Company reclassified Flagship store exit benefits into Stores and distribution expense on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income. There were no changes to Operating (loss) income or Net (loss) income. Prior period amounts have been reclassified to conform to current year’s presentation.
| | | | | | | | |
Abercrombie & Fitch Co. | 9 | 2022 2Q Form 10-Q |
Use of estimates
The preparation of financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. Due to the inherent uncertainty involved with estimates, actual results may differ. The extent to which the coronavirus disease (“COVID-19”) continues to impact the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the duration, spread and emergence of new variants of the virus, the availability and acceptance of effective vaccines, boosters or medical treatments, the impact of COVID-19 on the length or frequency of store closures, and the extent to which COVID-19 impacts worldwide macroeconomic conditions including interest rates, foreign currency exchange rates, and governmental, business and consumer reactions to the pandemic. The Company’s assessment of these, as well as other factors, such as the impact of a slowing economy, rising interest rates and continued inflation, could impact management's estimates and result in material impacts to the Company’s consolidated financial statements in future reporting periods.
Recent accounting pronouncements
The Company reviews recent accounting pronouncements on a quarterly basis and has excluded discussion of those not applicable to the Company and those that did not have, or are not expected to have, a material impact on the Company’s consolidated financial statements.
Condensed Consolidated Statements of Cash Flows reconciliation
The following table provides a reconciliation of cash and equivalents and restricted cash and equivalents to the amounts shown on the Condensed Consolidated Statements of Cash Flows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in thousands) | Location | | July 30, 2022 | | January 29, 2022 | | July 31, 2021 | | January 30, 2021 |
Cash and equivalents | Cash and equivalents | | $ | 369,957 | | | $ | 823,139 | | | $ | 921,504 | | | $ | 1,104,862 | |
Long-term restricted cash and equivalents | Other assets | | 10,077 | | | 11,229 | | | 14,268 | | | 14,814 | |
Short-term restricted cash and equivalents | Other current assets | | — | | | — | | | 267 | | | 4,481 | |
Cash and equivalents and restricted cash and equivalents | | | $ | 380,034 | | | $ | 834,368 | | | $ | 936,039 | | | $ | 1,124,157 | |
3. REVENUE RECOGNITION
Disaggregation of revenue
All revenues are recognized in net sales in the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income . For information regarding the disaggregation of revenue, refer to Note 14, “SEGMENT REPORTING.”
Contract liabilities
The following table details certain contract liabilities representing unearned revenue as of July 30, 2022, January 29, 2022 and July 31, 2021:
| | | | | | | | | | | | | | | | | | | | | |
(in thousands) | July 30, 2022 | | January 29, 2022 | | July 31, 2021 | | | | |
Gift card liability | $ | 35,205 | | | $ | 36,984 | | | $ | 29,038 | | | | | |
Loyalty programs liability | 21,525 | | | 22,757 | | | 20,962 | | | | | |
The following table details recognized revenue associated with the Company’s gift card program and loyalty programs for the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| Thirteen Weeks Ended | | Twenty-Six Weeks Ended |
(in thousands) | July 30, 2022 | | July 31, 2021 | | July 30, 2022 | | July 31, 2021 |
Revenue associated with gift card redemptions and gift card breakage | $ | 22,652 | | | $ | 17,353 | | | $ | 45,653 | | | $ | 33,509 | |
Revenue associated with reward redemptions and breakage related to the Company’s loyalty programs | 10,630 | | | 9,897 | | | $ | 20,811 | | | $ | 19,450 | |
| | | | | | | | |
Abercrombie & Fitch Co. | 10 | 2022 2Q Form 10-Q |
4. NET (LOSS) INCOME PER SHARE
Net (loss) income per basic and diluted share attributable to A&F is computed based on the weighted-average number of outstanding shares of Class A Common Stock (“Common Stock”). Additional information pertaining to net (loss) income per share attributable to A&F follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Thirteen Weeks Ended | | Twenty-Six Weeks Ended |
(in thousands) | July 30, 2022 | | July 31, 2021 | | July 30, 2022 | | July 31, 2021 |
Shares of Common Stock issued | 103,300 | | | 103,300 | | | 103,300 | | | 103,300 | |
Weighted-average treasury shares | (52,859) | | | (41,872) | | | (52,038) | | | (41,386) | |
Weighted-average — basic shares | 50,441 | | | 61,428 | | | 51,262 | | | 61,914 | |
Dilutive effect of share-based compensation awards | — | | | 2,708 | | | — | | | 2,889 | |
Weighted-average — diluted shares | 50,441 | | | 64,136 | | | 51,262 | | | 64,803 | |
Anti-dilutive shares (1) | 4,209 | | | 1,194 | | | 4,245 | | | 1,277 | |
(1)Reflects the total number of shares related to outstanding share-based compensation awards that have been excluded from the computation of net (loss) income per diluted share because the impact would have been anti-dilutive. Unvested shares related to restricted stock units with performance-based and market-based vesting conditions can achieve up to 200% of their target vesting amount and are reflected at the maximum vesting amount less any dilutive portion.
5. FAIR VALUE
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized based on a three-level hierarchy. The three levels of inputs to measure fair value are as follows:
•Level 1—inputs are unadjusted quoted prices for identical assets or liabilities that are available in active markets that the Company can access at the measurement date.
•Level 2—inputs are other than quoted market prices included within Level 1 that are observable for assets or liabilities, directly or indirectly.
•Level 3—inputs to the valuation methodology are unobservable.
The lowest level of significant input determines the placement of the entire fair value measurement in the hierarchy. The three levels of the hierarchy and the distribution of the Company’s assets measured at fair value on a recurring basis, as of July 30, 2022 and January 29, 2022, were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Assets and liabilities at Fair Value as of July 30, 2022 |
(in thousands) | Level 1 | | Level 2 | | Level 3 | | Total |
Assets: | | | | | | | |
Cash equivalents (1) | $ | 37,389 | | | $ | 9,900 | | | $ | — | | | $ | 47,289 | |
Derivative instruments (2) | — | | | 5,169 | | | — | | | 5,169 | |
Rabbi Trust assets (3) | 1 | | | 63,001 | | | — | | | 63,002 | |
Restricted cash equivalents (1) | 1,584 | | | 5,256 | | | — | | | 6,840 | |
Total assets | $ | 38,974 | | | $ | 83,326 | | | $ | — | | | $ | 122,300 | |
| | | | | | | |
Liabilities: | | | | | | | |
Derivative instruments (2) | $ | — | | | $ | 3 | | | $ | — | | | $ | 3 | |
Total liabilities | $ | — | | | $ | 3 | | | $ | — | | | $ | 3 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| Assets at Fair Value as of January 29, 2022 |
(in thousands) | Level 1 | | Level 2 | | Level 3 | | Total |
Assets: | | | | | | | |
Cash equivalents (1) | $ | 49,309 | | | $ | 11,643 | | | $ | — | | | $ | 60,952 | |
Derivative instruments (2) | — | | | 4,973 | | | — | | | 4,973 | |
Rabbi Trust assets (3) | 1 | | | 62,272 | | | — | | | 62,273 | |
Restricted cash equivalents (1) | 5,391 | | | 2,326 | | | — | | | 7,717 | |
Total assets | $ | 54,701 | | | $ | 81,214 | | | $ | — | | | $ | 135,915 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
(1) Level 1 assets consisted of investments in money market funds and U.S. treasury bills. Level 2 assets consisted of time deposits.
(2) Level 2 assets consisted primarily of foreign currency exchange forward contracts.
(3) Level 1 assets consisted of investments in money market funds. Level 2 assets consisted of trust-owned life insurance policies.
| | | | | | | | |
Abercrombie & Fitch Co. | 11 | 2022 2Q Form 10-Q |
The Company’s Level 2 assets consisted of:
•Trust-owned life insurance policies, which were valued using the cash surrender value of the life insurance policies;
•Time deposits, which were valued at cost, approximating fair value, due to the short-term nature of these investments and derivative instruments, primarily foreign currency exchange forward contracts, which were valued using quoted market prices of the same or similar instruments, adjusted for counterparty risk.
Fair value of long-term borrowings
The Company’s borrowings under its senior secured notes, which have a fixed 8.75% interest rate and mature on July 15, 2025 (the “Senior Secured Notes”) are carried at historical cost in the accompanying Condensed Consolidated Balance Sheets. The carrying amount and fair value of the Company’s long-term gross borrowings were as follows:
| | | | | | | | | | | |
(in thousands) | July 30, 2022 | | January 29, 2022 |
Gross borrowings outstanding, carrying amount | $ | 307,730 | | | $ | 307,730 | |
Gross borrowings outstanding, fair value | 302,729 | | | 327,732 | |
6. PROPERTY AND EQUIPMENT, NET
Property and equipment, net consisted of:
| | | | | | | | | | | |
(in thousands) | July 30, 2022 | | January 29, 2022 |
Property and equipment, at cost | $ | 2,462,069 | | | $ | 2,453,493 | |
Less: Accumulated depreciation and amortization | (1,950,888) | | | (1,945,157) | |
Property and equipment, net | $ | 511,181 | | | $ | 508,336 | |
Refer to Note 8, “ASSET IMPAIRMENT,” for details related to property and equipment impairment charges incurred during the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021.
7. LEASES
The Company is a party to leases related to its Company-operated retail stores as well as for certain of its distribution centers, office space, information technology and equipment.
The following table provides a summary of the Company’s operating lease costs for the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| Thirteen Weeks Ended | | Twenty-Six Weeks Ended |
(in thousands) | July 30, 2022 | | July 31, 2021 | | July 30, 2022 | | July 31, 2021 |
Single lease cost (1) | $ | 61,953 | | | $ | 70,325 | | | $ | 119,533 | | | $ | 140,077 | |
Variable lease cost (2) | 32,520 | | | 19,300 | | | 65,678 | | | 42,466 | |
Operating lease right-of-use asset impairment (3) | 1,573 | | | 240 | | | 3,488 | | | 2,704 | |
Sublease income (4) | (952) | | | (1,095) | | | (1,961) | | | (2,188) | |
Total operating lease cost | $ | 95,094 | | | $ | 88,770 | | | $ | 186,738 | | | $ | 183,059 | |
(1)Included amortization and interest expense associated with operating lease right-of-use assets and the impact from remeasurement of operating lease liabilities.
(2)Includes variable payments related to both lease and nonlease components, such as contingent rent payments made by the Company based on performance, and payments related to taxes, insurance, and maintenance costs, as well as the benefit of $0.9 million and $2.6 million of rent abatements during the thirteen and twenty-six weeks ended July 30, 2022, respectively, related to the effects of the COVID-19 pandemic that resulted in the total payments required by the modified contract being substantially the same as or less than total payments required by the original contract. The benefit related to rent abatements recognized during the thirteen and twenty-six weeks ended July 31, 2021 was $5.2 million and $13.0 million respectively.
(3)Refer to Note 8, “ASSET IMPAIRMENT,” for details related to operating lease right-of-use asset impairment charges. (4)The terms of the sublease agreement entered into by the Company with a third party during Fiscal 2020 related to one of its previous flagship store locations have not changed materially from that disclosed in Note 8, “LEASES,” of the Notes to Consolidated Financial Statements contained in “Item 8. Financial Statements and Supplementary Data” of the Fiscal 2021 Form 10-K. Sublease income is recognized in other operating (loss) income, net on the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income.
The Company suspended rent payments for a number of stores that were closed as a result of COVID-19, and has been successful in obtaining certain rent abatements and landlord concessions of rent payable.
| | | | | | | | |
Abercrombie & Fitch Co. | 12 | 2022 2Q Form 10-Q |
The Company had minimum commitments related to operating lease contracts that have not yet commenced, primarily for its Company-operated retail stores, of approximately $25.0 million as of July 30, 2022.
8. ASSET IMPAIRMENT
Asset impairment charges for the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021 were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| Thirteen Weeks Ended | | Twenty-Six Weeks Ended |
(in thousands) | July 30, 2022 | | July 31, 2021 | | July 30, 2022 | | July 31, 2021 |
Operating lease right-of-use asset impairment | $ | 1,573 | | | $ | 240 | | | $ | 3,488 | | | $ | 2,704 | |
Property and equipment asset impairment | 597 | | | 546 | | | 2,104 | | | 746 | |
Total asset impairment | $ | 2,170 | | | $ | 786 | | | $ | 5,592 | | | $ | 3,450 | |
Asset impairment charges for the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021 related to certain of the Company’s stores across brands, geographies and store formats. The impairment charges for the twenty-six weeks ended July 30, 2022 reduced the then carrying amount of the impaired stores’ assets to their fair value of approximately $16.9 million, including $16.1 million related to operating lease right-of-use assets. The impairment charges for the twenty-six weeks ended July 31, 2021 reduced the then carrying amount of the impaired stores’ assets to their fair value of approximately $9.4 million, including $8.8 million related to operating lease right-of-use assets.
9. INCOME TAXES
The quarterly provision for income taxes is based on the current estimate of the annual effective income tax rate and the tax effect of discrete items occurring during the quarter. The Company’s quarterly provision and the estimate of the annual effective tax rate are subject to significant variation due to several factors. These factors include variability in the pre-tax jurisdictional mix of earnings, changes in how the Company does business including entering into new businesses or geographies, changes in foreign currency exchange rates, changes in laws, regulations, interpretations and administrative practices, relative changes in expenses or losses for which tax benefits are not recognized and the impact of discrete items. In addition, jurisdictions where the Company anticipates an ordinary loss for the fiscal year for which the Company does not anticipate future tax benefits are excluded from the overall computation of estimated annual effective tax rate and no tax benefits are recognized in the period related to losses in such jurisdictions. The impact of these items on the effective tax rate will be greater at lower levels of pre-tax earnings.
On August 16, 2022, the Inflation Reduction Act was enacted into U.S. law. The Company does not currently expect that the Inflation Reduction Act will have a material impact on its income taxes.
Impact of valuation allowances and other tax charges
During the thirteen weeks ended July 30, 2022, the Company did not recognize income tax benefits on $26.4 million of pretax
losses, primarily in Switzerland, resulting in adverse tax impacts of $4.8 million.
During the twenty-six weeks ended July 30, 2022, the Company did not recognize income tax benefits on $39.8 million of pre-tax losses, primarily in Switzerland, resulting in adverse tax impacts of $7.2 million.
As of July 30, 2022, there were approximately $12.1 million of net deferred tax assets in China. The realization of these net deferred tax assets is dependent upon the future generation of sufficient taxable profits in China. During the thirteen weeks ended July 30, 2022, the company recorded a $0.2 million valuation allowance on net operating losses currently not projected to be utilized in future years. While the Company believes that the remaining net deferred tax assets are more-likely-than-not to be realized, it is not a certainty, as the Company continues to evaluate and respond to emerging situations, such as the COVID-19 pandemic. The company is closely monitoring its operations in China. Should circumstances change, the net deferred tax assets may become subject to additional valuation allowances in the future. Additional valuation allowances would result in additional tax expense.
During the thirteen weeks ended July 31, 2021, as a result of the improvement seen in business conditions, the Company recognized $23.5 million of discrete tax benefits due to the release of valuation allowances, primarily in the U.S. and Germany, and a discrete tax benefit of $3.9 million due to the impact of a statutory rate change in the U.K on the valuation of deferred tax assets. The Company also recognized $6.7 million of tax benefits due to the anticipated utilization of deferred tax assets against projected pre-tax income for the full fiscal year, primarily in the U.S. and Germany based on information available, on which a valuation allowance had previously been established.
During the twenty-six weeks ended July 31, 2021, as a result of the improvement seen in business conditions, the Company recognized $23.6 million of discrete tax benefits due to the release of valuation allowances, primarily in the U.S. and Germany,
| | | | | | | | |
Abercrombie & Fitch Co. | 13 | 2022 2Q Form 10-Q |
and a discrete tax benefit of $3.9 million due to the impact of a statutory rate change in the U.K on the valuation of deferred tax assets. The Company also recognized $10.1 million of tax benefits related to the utilization of deferred tax assets against projected pre-tax income for the full fiscal year, primarily in the U.S. and Germany, based on information available, on which a valuation allowance had previously been established.
The Company continues to maintain valuation allowances in certain jurisdictions, principally Japan and Switzerland.
Share-based compensation
Refer to Note 11, “SHARE-BASED COMPENSATION,” for details on income tax benefits and charges related to share-based compensation awards during the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021.
10. BORROWINGS
Details on the Company’s long-term borrowings, net, as of July 30, 2022 and January 29, 2022 are as follows:
| | | | | | | | | | | |
(in thousands) | July 30, 2022 | | January 29, 2022 |
Long-term portion of borrowings, gross at carrying amount | $ | 307,730 | | | $ | 307,730 | |
Unamortized fees | (3,511) | | | (4,156) | |
Long-term borrowings, net | $ | 304,219 | | | $ | 303,574 | |
Senior Secured Notes
The terms of the Senior Secured Notes have remained unchanged from those disclosed in Note 13, “BORROWINGS,” of the Notes to Consolidated Financial Statements contained in “Item 8. Financial Statements and Supplementary Data” of on the Fiscal 2021 Form 10-K.
ABL Facility
The terms of the Company’s senior secured revolving credit facility of up to $400.0 million (the “ABL Facility”) remained unchanged from those disclosed in Note 13, “BORROWINGS,” of the Notes to Consolidated Financial Statements contained in “Item 8. Financial Statements and Supplementary Data” of the Fiscal 2021 Form 10-K.
The Company did not have any borrowings outstanding under the ABL Facility as of July 30, 2022 or as of January 29, 2022.
As of July 30, 2022, availability under the ABL Facility was $399.2 million, net of $0.8 million in outstanding stand-by letters of credit. As the Company must maintain excess availability equal to the greater of 10% of the loan cap or $30 million under the ABL Facility, borrowing capacity available to the Company under the ABL Facility was $359.2 million as of July 30, 2022.
Representations, warranties and covenants
The agreements related to the Senior Secured Notes and the ABL Facility contain various representations, warranties and restrictive covenants that, among other things and subject to specified exceptions, restrict the ability of the Company and its subsidiaries to: grant or incur liens; incur, assume or guarantee additional indebtedness; sell or otherwise dispose of assets, including capital stock of subsidiaries; make investments in certain subsidiaries; pay dividends, make distributions or redeem or repurchase capital stock; change the nature of their business; and consolidate or merge with or into, or sell substantially all of the assets of the Company or Abercrombie & Fitch Management Co. (“A&F Management”), a wholly-owned indirect subsidiary of A&F, to another entity.
The Senior Secured Notes are guaranteed on a senior secured basis, jointly and severally, by A&F and each of the existing and future wholly-owned domestic restricted subsidiaries of A&F that guarantee or will guarantee A&F Management’s Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”) or certain future capital markets indebtedness.
Certain of the agreements related to the Senior Secured Notes and the ABL Facility also contain certain affirmative covenants, including reporting requirements such as delivery of financial statements, certificates and notices of certain events, maintaining insurance and providing additional guarantees and collateral in certain circumstances.
The Company was in compliance with all debt covenants under these agreements as of July 30, 2022.
| | | | | | | | |
Abercrombie & Fitch Co. | 14 | 2022 2Q Form 10-Q |
11. SHARE-BASED COMPENSATION
Financial statement impact
The following table details share-based compensation expense and the related income tax impacts for the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| Thirteen Weeks Ended | | Twenty-Six Weeks Ended |
(in thousands) | July 30, 2022 | | July 31, 2021 | | July 30, 2022 | | July 31, 2021 |
Share-based compensation expense | $ | 7,760 | | | $ | 6,487 | | | $ | 16,116 | | | $ | 14,937 | |
Income tax benefit associated with share-based compensation expense recognized | 1,015 | | | 1,388 | | | $ | 1,980 | | | $ | 1,686 | |
The following table details discrete income tax benefits and charges related to share-based compensation awards during the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| Thirteen Weeks Ended | | Twenty-Six Weeks Ended |
(in thousands) | July 30, 2022 | | July 31, 2021 | | July 30, 2022 | | July 31, 2021 |
Income tax discrete (charges) benefits realized for tax deductions related to the issuance of shares | $ | (113) | | | $ | 826 | | | $ | 1,998 | | | $ | 4,016 | |
Income tax discrete (charges) benefits realized upon cancellation of stock appreciation rights | (8) | | | — | | | (203) | | | (3) | |
Total income tax discrete (charges) benefits related to share-based compensation awards | $ | (121) | | | $ | 826 | | | $ | 1,795 | | | $ | 4,013 | |
The following table details the amount of employee tax withheld by the Company upon the issuance of shares associated with restricted stock units vesting and the exercise of stock appreciation rights for the thirteen and twenty-six weeks ended July 30, 2022 and July 31, 2021:
| | | | | | | | | | | | | | | | | | | | | | | |
| Thirteen Weeks Ended | | Twenty-Six Weeks Ended |
(in thousands) | July 30, 2022 | | July 31, 2021 | | July 30, 2022 | | July 31, 2021 |
Employee tax withheld upon issuance of shares (1) | $ | 312 | | | $ | 312 | | | $ | 14,006 | | | $ | 12,060 | |
(1) Classified within other financing activities on the Condensed Consolidated Statements of Cash Flows.
Restricted stock units
The following table summarizes activity for restricted stock units for the twenty-six weeks ended July 30, 2022:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Service-based Restricted Stock Units | | Performance-based Restricted Stock Units | | Market-based Restricted Stock Units |
| Number of Underlying Shares | | Weighted- Average Grant Date Fair Value |